Publicaciones en colaboración con investigadores/as de University of Amsterdam (21)

2026

  1. Asundexian for Secondary Stroke Prevention

    The New England journal of medicine, Vol. 394, Núm. 15, pp. 1467-1479

  2. Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction

    The New England journal of medicine, Vol. 394, Núm. 10, pp. 958-968

2025

  1. ASO Visual Abstract: Outcomes for Patients with Obesity Undergoing Adrenalectomy for Pheochromocytoma-An International Multicenter Analysis

    Annals of surgical oncology, Vol. 32, Núm. 4, pp. 2376-2378

  2. Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up?

    Annals of Oncology, Vol. 36, Núm. 11, pp. 1245-1262

  3. European guidelines on diagnosis and treatment of phenylketonuria: First revision

    Molecular Genetics and Metabolism, Vol. 145, Núm. 2

  4. Evaluation of the effect of tumour size on outcomes for patients undergoing adrenalectomy for phaeochromocytoma: international multicentre analysis

    BJS Open, Vol. 9, Núm. 6

  5. Outcomes for Patients with Obesity Undergoing Adrenalectomy for Pheochromocytoma: An International Multicenter Analysis

    Annals of Surgical Oncology, Vol. 32, Núm. 3, pp. 1709-1720

  6. Postoperative Outcomes in Normotensive and Hypertensive Pheochromocytomas: An International Study

    Journal of Clinical Endocrinology and Metabolism, Vol. 110, Núm. 11, pp. e3719-e3729

  7. Robotic and Laparoscopic Adrenalectomy for Pheochromocytoma: An International Multicenter Study

    European Urology Focus, Vol. 11, Núm. 1, pp. 118-125

  8. Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe

    Thrombosis and Haemostasis, Vol. 125, Núm. 9, pp. 880-892

2024

  1. Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)

    Journal of Allergy and Clinical Immunology, Vol. 153, Núm. 6, pp. 1553-1562

  2. The Association between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC)

    American journal of respiratory and critical care medicine, Vol. 210, Núm. 1, pp. 119-127

2022

  1. Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

    Annals of Internal Medicine, Vol. 174, Núm. 6, pp. 768-776

2020

  1. Beta-blocker effect on ST-segment: A prespecified analysis of the EARLY-BAMI randomised trial

    Open Heart, Vol. 7, Núm. 2

2019

  1. Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals with Sustained Virological Suppression on Antiretroviral Therapy

    Journal of Acquired Immune Deficiency Syndromes, Vol. 80, Núm. 3, pp. 292-300

  2. Effectiveness of Transmitted Drug Resistance Testing before Initiation of Antiretroviral Therapy in HIV-Positive Individuals

    Journal of Acquired Immune Deficiency Syndromes, Vol. 82, Núm. 3, pp. 314-320

2018

  1. 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

    European Heart Journal, Vol. 39, Núm. 14, pp. 1131-1143

  2. Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance

    AIDS, Vol. 32, Núm. 3, pp. 327-335

  3. Factors associating with differences in the incidence of renal replacement therapy among elderly: Data from the ERA-EDTA Registry

    Nephrology Dialysis Transplantation, Vol. 33, Núm. 8, pp. 1428-1435